142 related articles for article (PubMed ID: 28112486)
1. Pleural fluid cytology samples in cases of suspected lung cancer: An experience from a tertiary care centre.
Kaur G; Nijhawan R; Gupta N; Singh N; Rajwanshi A
Diagn Cytopathol; 2017 Mar; 45(3):195-201. PubMed ID: 28112486
[TBL] [Abstract][Full Text] [Related]
2. The diagnostic utility of D2-40 for malignant mesothelioma versus pulmonary carcinoma with pleural involvement.
Saad RS; Lindner JL; Lin X; Liu YL; Silverman JF
Diagn Cytopathol; 2006 Dec; 34(12):801-6. PubMed ID: 17115439
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of cell blocks from effusion specimens in Gynecologic Oncopathology: An experience of 220 cases, diagnosed at a Tertiary Cancer Referral Center.
Rekhi B; Karmarkar S; Gupta C; Deodhar KK; Menon S; Pathuthara S; Maheshwari A; Shylasree TS; Gupta S
Indian J Pathol Microbiol; 2020; 63(3):427-434. PubMed ID: 32769333
[TBL] [Abstract][Full Text] [Related]
4. Thyroid transcription factor-1 is highly sensitive and specific in differentiating metastatic pulmonary from extrapulmonary adenocarcinoma in effusion fluid cytology specimens.
Ng WK; Chow JC; Ng PK
Cancer; 2002 Feb; 96(1):43-8. PubMed ID: 11836702
[TBL] [Abstract][Full Text] [Related]
5. Demographic, clinical, biochemical, radiological and etiological characteristics of malignant pleural effusions from Eastern India.
Saha K; Maikap MK; Maji A; Moitra M; Jash D
Indian J Cancer; 2017; 54(1):257-261. PubMed ID: 29199701
[TBL] [Abstract][Full Text] [Related]
6. Metastatic breast carcinoma in pleural fluid: Correlation of receptor and HER2 status with the primary carcinoma-a pilot study.
Francis IM; Alath P; George SS; Jaragh M; Al Jassar A; Kapila K
Diagn Cytopathol; 2016 Dec; 44(12):980-986. PubMed ID: 27666130
[TBL] [Abstract][Full Text] [Related]
7. [Pleural effusion cytology of asbestos-associated malignant mesothelioma and lung carcinoma in the diagnosis of occupational diseases by the statutory accident insurance funds].
Biesterfeld S; Schramm M; Schad A; Pomjanski N
Pneumologie; 2014 Apr; 68(4):270-6. PubMed ID: 24615665
[TBL] [Abstract][Full Text] [Related]
8. A fine decision tree consisted of CK5/6, IMP3 and TTF1 for cytological diagnosis among reactive mesothelial cells, metastatic adenocarcinoma of lung and non-lung origin in pleural effusion.
Yan J; Wei Q; Jian W; Liu J; Tang H; Ge J; Zhou J; Zhao T
Int J Clin Exp Pathol; 2014; 7(9):5810-8. PubMed ID: 25337222
[TBL] [Abstract][Full Text] [Related]
9. Metastatic thyroid carcinoma presenting as malignant pleural effusion: A cytologic review of 5 cases.
Vyas M; Harigopal M
Diagn Cytopathol; 2016 Dec; 44(12):1085-1089. PubMed ID: 27456348
[TBL] [Abstract][Full Text] [Related]
10. [A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation].
Szczepulska-Wójcik E; Langfort R; Roszkowski-Sliz K
Pneumonol Alergol Pol; 2007; 75(1):57-69. PubMed ID: 17541913
[TBL] [Abstract][Full Text] [Related]
11. The value of calretinin and cytokeratin 5/6 as markers for mesothelioma in cell block preparations of serous effusions.
Shield PW; Koivurinne K
Cytopathology; 2008 Aug; 19(4):218-23. PubMed ID: 17916095
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic utility of D2-40, calretinin, CK5/6, desmin and MOC-31 in the differentiation of mesothelioma from adenocarcinoma in pleural effusion cytology.
Hyun TS; Barnes M; Tabatabai ZL
Acta Cytol; 2012; 56(5):527-32. PubMed ID: 23075894
[TBL] [Abstract][Full Text] [Related]
13. Detection of EML4-ALK in lung adenocarcinoma using pleural effusion with FISH, IHC, and RT-PCR methods.
Liu L; Zhan P; Zhou X; Song Y; Zhou X; Yu L; Wang J
PLoS One; 2015; 10(3):e0117032. PubMed ID: 25785456
[TBL] [Abstract][Full Text] [Related]
14. [Significance of combining detection of E-cadherin, carcinoembryonic antigen, and calretinin in cytological differential diagnosis of serous effusion].
Su XY; Li GD; Liu HB; Jiang LL
Ai Zheng; 2004 Oct; 23(10):1185-9. PubMed ID: 15473932
[TBL] [Abstract][Full Text] [Related]
15. Subtle pleural metastasis without large effusion in lung cancer patients: preoperative detection on CT.
Hwang JH; Song KS; Park SI; Lim TH; Kwon KH; Goo DE
Korean J Radiol; 2005; 6(2):94-101. PubMed ID: 15968148
[TBL] [Abstract][Full Text] [Related]
16. Malignant pleural effusion resulting from metastasis of thyroid primaries: a cytomorphological analysis.
Olson MT; Nuransoy A; Ali SZ
Acta Cytol; 2013; 57(2):177-83. PubMed ID: 23406984
[TBL] [Abstract][Full Text] [Related]
17. Carcinoma of the lung in HIV-positive patients: findings on chest radiographs and CT scans.
White CS; Haramati LB; Elder KH; Karp J; Belani CP
AJR Am J Roentgenol; 1995 Mar; 164(3):593-7. PubMed ID: 7863877
[TBL] [Abstract][Full Text] [Related]
18. The Role of Immunohistochemistry Studies in Distinguishing Malignant Mesothelioma from Metastatic Lung Carcinoma in Malignant Pleural Effusion.
Halimi M; BeheshtiRouy S; Salehi D; Rasihashemi SZ
Iran J Pathol; 2019; 14(2):122-126. PubMed ID: 31528168
[TBL] [Abstract][Full Text] [Related]
19. Pleural effusion in lung cancer.
Sahn SA
Clin Chest Med; 1993 Mar; 14(1):189-200. PubMed ID: 8384963
[TBL] [Abstract][Full Text] [Related]
20. Utility of WT-1, p63, MOC31, mesothelin, and cytokeratin (K903 and CK5/6) immunostains in differentiating adenocarcinoma, squamous cell carcinoma, and malignant mesothelioma in effusions.
Pu RT; Pang Y; Michael CW
Diagn Cytopathol; 2008 Jan; 36(1):20-5. PubMed ID: 18064689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
